Haemonetics Corp
HAE59.340USD
-5.695-8.76%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
2.78BMarktkapitalisierung
16.30KGV TTM
mehr Informationen über Haemonetics Corp Unternehmen
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Haemonetics Corp Informationen
BörsenkürzelHAE
Name des UnternehmensHaemonetics Corp
IPO-datumOct 17, 1979
CEOSimon (Christopher A)
Anzahl der mitarbeiter3023
WertpapierartOrdinary Share
GeschäftsjahresendeOct 17
Addresse125 Summer Street
StadtBOSTON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl02110
Telefon17818487100
Websitehttps://www.haemonetics.com
BörsenkürzelHAE
IPO-datumOct 17, 1979
CEOSimon (Christopher A)
Führungskräfte von Haemonetics Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.01K
-238.00%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+2693.00%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+2693.00%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
24.76K
+1400.00%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+406.00%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+2693.00%
Mr. Michael J. Coyle
Mr. Michael J. Coyle
Independent Director
Independent Director
15.39K
+2693.00%
Ms. Diane M. Bryant
Ms. Diane M. Bryant
Independent Director
Independent Director
7.13K
+2693.00%
Mr. Roy Galvin
Mr. Roy Galvin
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.24K
-145.00%
Mr. Christopher A. Simon
Mr. Christopher A. Simon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.01K
-238.00%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+2693.00%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+2693.00%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
24.76K
+1400.00%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+406.00%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+2693.00%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
240.09M
73.35%
Europe
42.97M
13.13%
Asia
22.57M
6.89%
Japan
18.01M
5.50%
other
3.68M
1.13%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Sat, Jan 31
Aktualisiert: Sat, Jan 31
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
11.41%
The Vanguard Group, Inc.
10.22%
Neuberger Berman, LLC
7.90%
AQR Capital Management, LLC
4.58%
State Street Investment Management (US)
3.87%
Andere
62.02%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
11.41%
The Vanguard Group, Inc.
10.22%
Neuberger Berman, LLC
7.90%
AQR Capital Management, LLC
4.58%
State Street Investment Management (US)
3.87%
Andere
62.02%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
47.59%
Investment Advisor/Hedge Fund
45.89%
Hedge Fund
9.46%
Research Firm
4.39%
Bank and Trust
1.38%
Individual Investor
1.24%
Sovereign Wealth Fund
1.14%
Pension Fund
1.03%
Family Office
0.11%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
709
51.33M
109.66%
-8.77M
2025Q3
697
54.60M
116.65%
-5.18M
2025Q2
700
57.31M
118.95%
-4.19M
2025Q1
723
57.94M
120.44%
-3.07M
2024Q4
701
58.48M
116.40%
-1.44M
2024Q3
689
57.60M
112.60%
-1.51M
2024Q2
668
57.60M
113.31%
+3.07M
2024Q1
655
52.49M
103.35%
-1.26M
2023Q4
647
51.85M
102.19%
-3.31M
2023Q3
657
52.00M
102.54%
-4.11M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
5.30M
11.33%
-267.30K
-4.80%
Sep 30, 2025
The Vanguard Group, Inc.
4.82M
10.3%
-118.69K
-2.40%
Sep 30, 2025
Neuberger Berman, LLC
3.67M
7.84%
-607.17K
-14.19%
Sep 30, 2025
AQR Capital Management, LLC
2.13M
4.55%
+1.68M
+372.82%
Sep 30, 2025
State Street Investment Management (US)
1.80M
3.85%
-83.25K
-4.42%
Sep 30, 2025
River Road Asset Management, LLC
1.65M
3.54%
-886.00
-0.05%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.20M
2.57%
-41.24K
-3.31%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.10M
2.35%
+26.76K
+2.49%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
1.01M
2.16%
-583.91K
-36.61%
Sep 30, 2025
Allspring Global Investments, LLC
1.06M
2.27%
+111.31K
+11.72%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Neuberger Berman Small-Mid Cap ETF
2.34%
State Street SPDR S&P Health Care Equipment ETF
1.66%
Harbor Human Capital Factor US Small Cap ETF
1.51%
Lattice Hartford Multifactor Small Cap ETF
0.54%
Inspire Small/Mid Cap ESG ETF
0.34%
WisdomTree US SmallCap Quality Growth Fund
0.3%
Principal U.S. Small-Cap ETF
0.28%
VictoryShares US Small Mid Cap Value Momentum ETF
0.26%
Royce Quant Small-Cap Quality Value ETF
0.24%
Amplify Etho Climate Leadership U.S. ETF
0.22%
Mehr Anzeigen
Neuberger Berman Small-Mid Cap ETF
Anteil2.34%
State Street SPDR S&P Health Care Equipment ETF
Anteil1.66%
Harbor Human Capital Factor US Small Cap ETF
Anteil1.51%
Lattice Hartford Multifactor Small Cap ETF
Anteil0.54%
Inspire Small/Mid Cap ESG ETF
Anteil0.34%
WisdomTree US SmallCap Quality Growth Fund
Anteil0.3%
Principal U.S. Small-Cap ETF
Anteil0.28%
VictoryShares US Small Mid Cap Value Momentum ETF
Anteil0.26%
Royce Quant Small-Cap Quality Value ETF
Anteil0.24%
Amplify Etho Climate Leadership U.S. ETF
Anteil0.22%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
